Examining Self-Reported Symptoms in Patients With Multiple Myeloma
Joshua R. Richter, MD, a hematologist/oncologist at John Theurer Cancer Center, discusses results from the Living with Cancer patient-reported outcomes (PROs) tool, which is a survey to record self-reported symptoms from patients. Richter used this tool to survey 239 patients with multiple myeloma on their symptoms and psychological distress.
Joshua R. Richter, MD, a hematologist/oncologist at John Theurer Cancer Center, discusses results from the Living with Cancer patient-reported outcomes (PROs) tool, which is a survey to record self-reported symptoms from patients. Richter used this tool to survey 239 patients with multiple myeloma on their symptoms and psychological distress.
The PROs tool identifies 4 different domains of personhood: performance status, burden, pain, and depression. The patients are asked questions, and then individually weight their response to each question, which is helpful in discovering what is of most importance to each patient. One might experience pain a lot of the time, while it is not very meaningful to their daily life, while another patient could experience little pain that they do consider meaningful to their life.
Real-World RRMM Data Explore Dose Deescalation and Outpatient Use of Teclistamab
November 18th 2024During a Case-Based Roundtable® event, Hana Safah, MD, examined several real-world studies of dose frequency and outpatient administration of teclistamab in patients with multiple myeloma in the first article of a 2-part series.
Read More
